Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 326-332

  Gorai, Itsuo ^a   Taguchi, Yasuto ^a   Chaki, Osamu ^a   Kikuchi, Ritsuko ^a   Nakayama, Masaki ^a   Yang, Bing Chen ^a   Yokota, Shumpei ^a   Minaguchi, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; CYTOKINE; DEOXYPYRIDINOLINE; ESTRADIOL; INTERLEUKIN 6 RECEPTOR; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE;

ADULT; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; FEMALE; FOLLICULAR PHASE; HUMAN; MENSTRUAL CYCLE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0031763629     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.2.4584     Document Type: Article

References (52)

1. Prestwood KM, Pilbeam CC, Burleson JA, et al. 1994 The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab. 79:366-371.
2. Pacifici R, Rifas L, McCracken R, et al. 1989 Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA. 86:2398-2402.
3. Pacifici R, Brown C, Puscheck E, et al. 1991 Effect of surgical menopausal and estrogen replacement on cytokine release from human blood mononuclear cell. Proc Natl Acad Sic USA. 88:5134-5138.
4. Jilka RJ, Hangoc G, Girasole G, et al. 1992 Increased osteoclast development after estrogen loss. Mediation by interleukin-6. Science. 257:88-91.
5. Tamura T, Udagawa N, Takahashi N, et al. 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 90:11924-11928.
6. Johansen JS, Riis BJ, Hassager C, Moen M, Jacobson J, Christiansen C. 1988 The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab. 67:701-706.
7. Compston JE, Yamaguchi K, Croucher PI, Garrahan NJ, Lindsay PC, Shaw RW. 1995 The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis. Bone 16:261-267.
8. Marshall LA, Cain DF, Dmowski WP, Chesnut III CH. 1996 Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy. Obstet Gynecol. 87:350-354.
9. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. 1996 Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and post menopausal women. J Clin Invest. 97:14-21.
10. Hata K, Tokuhiro H, Nakatsuka K, et al. 1996 Measurement of bone-specific alkaline phosphataseby an immunoselective enzyme assay method. Ann Clin Biochem. 33:127-131.
11. Melkko J, Niemi S, Risteli L, Risteli J. 1990 Radioimmunoassay for the carboxyterminal propeptide of human type I procollagen. Clin Chem. 36:1328-1332.
12. Hosoda K, Eguchi H, Nakamoto T, et al. 1992 A sandwich immunoassay for human intact osteocalcin. Clin Chem. 38:2233-2238.
13. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. 1942 Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res. 7:1384-1398.
14. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. 1994 Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem. 40:2022-2025.
15. Garnero P, Gineyts E, Riou JP, Delmas PD. 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab. 79:780-785.
16. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. 1994 Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res. 9:1643-1649.
17. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. 1993 Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 39.635-640.
18. Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E. 1975 Metabolism of immunoreactive parathyroid hormone in the dog. J Clin Invest. 56:39-48.
19. Pandian MR, Morgan CH, Carton E, Segre GV. 1992 Modified immunoradiometric assay of parathyroid hormone-related prorein:clinical application in the differential diagnosis of hypercalcemia. Clin Chem. 38:282-288.
20. Nielsen HK, Brixen K, Bouillon R, Mosekilde L. 1990 Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab. 70:1431-1437.
21. Maruo N, Chen JT, Ogata E, Shiraki M, Morita I. 1996 Serum level of soluble interleukin 6 receptor is correlated with the change of bone metabolism during cstrogen therapy. J Bone Miner Res 11[Suppl 1]:S118.
22. Bismar H, Diel I, Ziegler R, Pfeilschifter J. 1995 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab. 80:3351-3355.
23. Kassem M, Khosla S, Spelsberg TC, Riggs BL. 1996 Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab. 81:513-518.
24. DeMerre LJ, Lotosky FS. 1968 Alkaline-phosphatase activity during menstruation. Fertil Steril. 19:593-597.
25. Pitkin RM, Reynolds AR, Williams GA, Hargis KG. 1978 Calcium-regulating hormones during the menstrual cycle. J Clin Endocrinol Metab. 47:626-632.
26. Baran DT, Whyte MP, Haussler MR, Deftos LJ, Slatopolsky E, Avioli LV. 1980 Effect of the menstrual cycle on calcium-regulating hormone in the normal young women. J Clin Endocrinol Metab. 50:377-379.
27. Gray TK, McAdoo T, Hatley L, Lester GE, Thierry M. 1982 Fluctuation of serum concentration of 1,25-dihydroxyvitamin D, during the menstrual cycle. Am J Obstet Gynecol. 144:880-884.
28. Tjellesen L, Christiansen C, Hummer L, Larsen NE. 1983 Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle. Acta Endocrinol (Copenh). 102:476-480.
29. Muse KN, Manolagas SC, Deftos LJ, Alexander N, Yen SSC. 1986 Calcium-regulating hormones across the menstrual cycle. J Clin Endocrinol Metab. 62:1313-1315.
30. Buchanan JR, Santen RJ, Cavaliere A, Cauffman SW, Greer RB, Demers LM. 1986 Interaction between parathyroid hormone and endogenous estrogen in normal women. Metabolism. 35:489-494.
31. El-Hajj Fuleihan G, Hall JE, Porrino N, Gleason R, Crowley Jr WF. 1993 Intact parathyroid hormone levels across the menstrual cycle. J Bone Miner Res 8[Suppl 1]:S188.
32. Komm BS, Terpening CH, Benz DJ, et al. 1988 Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcom cells. Science. 241:81-84.
33. Eriksen EF, Colvard DS, Berg NJ, et al. 1488 Evidence of estrogen receptors in normal ostenblast cells. Science. 241:84-86.
34. Pensler JM, Radosevich JA, Higbee R, Langman CB. 1990 Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res. 5:797-802.
35. Chen TL, Aronow L, Feldman D. 1977 Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology. 100:619-628.
36. Price PA, Nishimoto S. 1980 Radioimmunoassay for the vitamin K-dependent protein found in bone and its discovery in plasma. Proc Natl Acad Sci USA. 77:2234-2239.
37. Parfitt AM, Simon LS, Villanueva AR, Krane SM. 1987 Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res. 2:427-436.
38. Hassager C, Jensen LT, Johansen JS, et al. 1991 The carboxyterminal propeptide of type I collagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism. 40:205-208.
39. Hasling C, Eriksen EF, Melkko J, et al. 1991 Effect of a combined estrogen-gestagen regimen on serum levels of the carboxyterminal propeptide of human type I procollagen on osteoporosis. J Bone Miner Res. 6:1295-1300.
40. Ebeling PR, Alley LM, Guthrie JR, et al. 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endcrinol Metab. 81:3366-3371.
41. Khosla S, Atkinson EJ, Melton III LJ, Riggs BL. 1497 Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab. 82:1522-1527.
42. Ernst M, Schmid CH, Froesch ER. 1988 Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA. 85:2307-2310.
43. Thys-Jacobs S, Alvir MJ. 1995 Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab. 80:2227-2232.
44. Gallagher JC, Riggs BL, DeLuca HF. 1980 Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 51:1359-1364.
45. Riggs BL, Jowsey J, Goldsmith RS, Kelly PJ, Hoffman DL, Arnaud CD. 1972 Short-and long-term effects of estrogen and synthetic anabolic hormones in postmenopausal osteoporosis. J Clin Invest. 51:1659-1663.
46. Riggs BL. 1979 Postmenopausal and senile osteoporosis: current concepts of etiology and treatment. Endocrinol Jpn SR. 1:31-41.
47. Greenberg C, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams EN. 1984 Effect of estradiol and progesterone on parathyroid hormone secretion. 6th Annual Scientific Meeting of the American Society for Bone and Mineral Research, Hartford, CT. p A54.
48. Gorai I, Chaki O, Nakayama M, Minaguchi H. 1995 Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int. 57:100-104.
49. Schlemmer A, Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C. 1993 Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol (Copenh). 129:388-392.
50. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. 1993 Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation to bone histomorphometry. J Bone Miner Res. 8:127-132.
51. Davison JM, Noble MBC. 1981 Serial changes in 24 hour creatinine clearance during the normal menstrual cycle and the first trimester off pregnancy. Br J Obstet Gynecol. 88:10-17.
52. 2-microglobulin and serum water during the menstrual cycle. Acta Med Scand. 221:191-197.